從廣(guang)東(dong)省(sheng)農(nong)藥工(gong)業(ye)(ye)協(xie)會獲悉,國(guo)家發改(gai)委日前公布(bu)了2007年第(di)一(yi)批農(nong)藥企業(ye)(ye)延(yan)續核準名單,包括江門大光明農(nong)化有限公司等在內的12家廣(guang)東(dong)農(nong)藥企業(ye)(ye)名列其中。
根(gen)據國(guo)家(jia)發(fa)改(gai)委辦公廳(ting)[2005]1191文件要求,2000年以(yi)前核(he)(he)準過或(huo)取(qu)得有效(xiao)生產許可證和登(deng)記證的(de)農(nong)藥企(qi)業(ye),2006年12月(yue)底前必須(xu)完成延續核(he)(he)準手續,逾期不能辦理(li)。為(wei)此,廣(guang)(guang)(guang)東省大(da)多農(nong)藥企(qi)業(ye)已(yi)(yi)經將(jiang)資(zi)料(liao)報送國(guo)家(jia)發(fa)改(gai)委核(he)(he)準,據廣(guang)(guang)(guang)東省農(nong)藥工業(ye)協(xie)會秘書長黃榮珍介紹,截至目前,廣(guang)(guang)(guang)東農(nong)藥企(qi)業(ye)已(yi)(yi)先后分四批總共(gong)43家(jia)企(qi)業(ye)報送了相關資(zi)料(liao)。
經過發改委(wei)的嚴格審(shen)核(he)和現場考察,12家(jia)廣(guang)(guang)東農(nong)(nong)藥(yao)企(qi)業順利通過延(yan)續(xu)審(shen)核(he),其中(zhong),江門大光明農(nong)(nong)化有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)獲(huo)得(de)農(nong)(nong)藥(yao)原藥(yao)生(sheng)產資(zi)格;佛山市(shi)(shi)南海奧帝精細(xi)化工(gong)(gong)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、廣(guang)(guang)東德(de)利生(sheng)物(wu)科技(ji)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、廣(guang)(guang)東廣(guang)(guang)州(zhou)市(shi)(shi)化學工(gong)(gong)業研(yan)究所、廣(guang)(guang)東廣(guang)(guang)州(zhou)粵(yue)果農(nong)(nong)業化學科技(ji)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、江門市(shi)(shi)新會區農(nong)(nong)得(de)豐(feng)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、羅定市(shi)(shi)生(sheng)物(wu)化工(gong)(gong)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、深圳諾普信(xin)農(nong)(nong)化股(gu)份有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、深圳市(shi)(shi)沃科生(sheng)物(wu)工(gong)(gong)程有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、廣(guang)(guang)東中(zhong)山富(fu)士化工(gong)(gong)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、珠(zhu)海真綠色(se)技(ji)術(shu)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、中(zhong)山欖菊(ju)日用制品(pin)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)(衛生(sheng)用藥(yao))等11家(jia)農(nong)(nong)藥(yao)企(qi)業獲(huo)得(de)延(yan)續(xu)核(he)準其農(nong)(nong)藥(yao)原藥(yao)制劑生(sheng)產資(zi)格。
農(nong)藥(yao)(yao)企(qi)業(ye)(ye)(ye)(ye)的(de)延(yan)續(xu)核(he)準(zhun)管(guan)理(li)(li)是國(guo)家(jia)修訂完善《農(nong)藥(yao)(yao)管(guan)理(li)(li)辦法》后(hou)新(xin)實施的(de)一(yi)項業(ye)(ye)(ye)(ye)務(wu)管(guan)理(li)(li)工(gong)作(zuo),也是國(guo)家(jia)為加(jia)強對農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)的(de)管(guan)理(li)(li)、提(ti)升農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)的(de)素質和水平而采取的(de)一(yi)項重要措施。根據(ju)要求,本次(ci)農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)延(yan)續(xu)核(he)準(zhun)有(you)效(xiao)期為5年,五年后(hou)要求延(yan)續(xu)保留農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)資(zi)(zi)格的(de)企(qi)業(ye)(ye)(ye)(ye),應當在(zai)有(you)效(xiao)期屆滿三個(ge)月前向國(guo)家(jia)發展改(gai)革委提(ti)出申請;通過(guo)延(yan)續(xu)核(he)準(zhun)的(de)農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)不得將(jiang)廠(chang)房、生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)設(she)備(bei)(bei)(bei)(bei)、分析檢(jian)測(ce)設(she)備(bei)(bei)(bei)(bei)、污水處理(li)(li)裝置等租賃給其(qi)他企(qi)業(ye)(ye)(ye)(ye)使用。逾期未通過(guo)延(yan)續(xu)核(he)準(zhun)的(de)企(qi)業(ye)(ye)(ye)(ye)其(qi)獲(huo)得的(de)農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)資(zi)(zi)格自動(dong)取消;通過(guo)延(yan)續(xu)核(he)準(zhun)的(de)農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)資(zi)(zi)質不準(zhun)轉讓,企(qi)業(ye)(ye)(ye)(ye)更名(ming)須報國(guo)家(jia)發展改(gai)革委備(bei)(bei)(bei)(bei)案并公(gong)示(shi),未經更名(ming)備(bei)(bei)(bei)(bei)案并公(gong)示(shi)的(de)企(qi)業(ye)(ye)(ye)(ye)將(jiang)不具(ju)備(bei)(bei)(bei)(bei)合(he)法的(de)農(nong)藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)(chan)(chan)(chan)企(qi)業(ye)(ye)(ye)(ye)資(zi)(zi)格。
據介紹,本次延續核準的企業注冊資金最低要求為:原藥企業1000萬元,制劑(加工、復配)企業500萬元,鼠藥制劑、分裝、衛生用藥企業200萬元。制劑(加工、復配)企業新增原藥需重新核準。對于本次延續核準未通過的企業申請材料,不再作為下一次申請延續核準的依據。
|